European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical OncologyHumansStomach NeoplasmsPaclitaxelPeritoneal NeoplasmsAntineoplastic Agents
Efficacy and safety of intraperitoneal paclitaxel-based regimens in patients with gastric cancer and peritoneal metastasis: A systematic review and meta-analysis.
Muhammad Bakhtiar, Sepideh Razi, Rabeea Ahmed, Mahnoor Mahnoor, Ahmad Ismail, Samer AlMasri, Geoffrey Nunns, Alessandro Paniccia, Melanie C Ongchin, Amer Zureikat, James Pingpank, Haroon Choudry, Anwaar Saeed
Published: 202610.1016/j.ejso.2025.111299
Abstract
Gastric cancer is a leading cause of cancer-related death worldwide. Peritoneal metastasis (PM) occurs in 5-20 % of patients at diagnosis and is associated with poor prognosis and limited treatment options. Intraperitoneal paclitaxel (IP PTX) has sho…
Preview only. Read the full abstract at the source